As a result of our acquisition of Mentor Planning & Consulting, we are very proud to expand our portfolio of services. Since 1993, Mentor has provided travel and meetings management consulting and planning services to clients in the pharmaceutical, medical, financial, legal, engineering, consumer products and high-tech sectors. In 2005, Mentor established a pharmaceutical consulting division that continues to focus on Phase 2 and Phase 3 clinical trials, as well as KOL development within a number of therapeutic areas.

Mentor has developed a niche in supporting pharmaceutical and medical technology clients focused on Pulmonary Hypertension (PAH, CTEPH), Neurology (Parkinson’s, Alzheimer’s, Schizophrenia, Dementia and Depression) and Infectious Diseases (HIV/AIDS, Hepatitis, C. difficile), but has also worked in a number of other therapeutic areas, including:

  • Hematology [Sickle Cell Disease]
  • Ophthalmology [Macular Degeneration, Uveitis]
  • Nephrology [Chronic Kidney Disease]
  • Gastroenterology [Irritable Bowel Syndrome, Ulcerative Colitis]
  • Oncology [Acute Myeloid Leukemia, Ovarian Cancer]
  • Endocrinology [Cushing Syndrome, Diabetes]

Mentor has built an outstanding reputation for integrity in dealing with clients and vendor partners, an unparalleled attention to detail, personalized “high-touch” service in all its dealings, and innovative solutions that offer measurable results. To learn more, visit